NIH-funded research R01 grant

Hydrogels that kill bacteria to help heal bone fractures

Official title: Bactericidal hydrogels for bone repair

Funded at Georgia Institute of Technology · NIH-11083622 · Data updated 2026-11-12

This study is testing new gel-like materials that can deliver antibiotics and a special enzyme right to infected bone fractures to help heal them better and reduce the need for other medications, making it a promising option for people dealing with bone injuries and infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionGeorgia Institute of Technology
NIH-funded
Lab location1 site (Atlanta, United States)
Project startMay 3, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$421,450
NIH project number5R01AR083702-02
Project IDNIH-11083622 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with bone fractures or non-union defects that are at risk of bacterial infection.

Less likely to help

Patients with bone injuries that are not infected or those who do not require surgical intervention may not benefit from this research.

What this research studies

This research focuses on developing innovative hydrogels that can deliver antibiotics and an enzyme called lysostaphin directly to infected bone fractures. By targeting bacterial infections at the site of injury, the goal is to improve healing outcomes and reduce the need for systemic antibiotics, which can have side effects. The research will be conducted using animal models to test the effectiveness of these hydrogels in eliminating infections and promoting bone repair. If successful, this approach could lead to better treatment options for patients with bone injuries complicated by infections.

Why it matters

Potential benefit: If successful, this research could provide a more effective treatment for bone fractures that are complicated by bacterial infections, potentially reducing recovery time and improving patient outcomes.

How similar studies have gone: Other research has shown promise in using localized delivery systems for antibiotics, suggesting that this approach could be effective, although the specific use of hydrogels in this context is relatively novel.

Where this research is happening

  • Georgia Institute of Technology
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Garcia, Andres J — Georgia Institute of Technology
  • Study coordinator: Garcia, Andres J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.